Who Supplies Fenofibrate? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Fenofibrate exports, with 168+ registered manufacturers shipping to buyers across 81+ countries — yet a handful of companies dominate the shipments. ABBOTT HEALTHCARE PRIVATE LIMITED holds the largest share at 11.7% (export value: $8.6M). Close behind, SUN PHARMACEUTICAL INDUSTRIES LIMITED (8.6%, $6.3M). CIPLA LIMITED (7.6%, $5.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Fenofibrate? Top Manufacturers & Their Buyers
Flow of Fenofibrate from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Fenofibrate Supplier Network — Key Market Intelligence
The Fenofibrate export market from India is led by ABBOTT HEALTHCARE PRIVATE LIMITED, which alone commands a 11.7% share, shipping $8.6M worth of product across 50 shipments. The second-largest exporter, SUN PHARMACEUTICAL INDUSTRIES LIMITED, contributes $6.3M (8.6%) to the overall market. Combined, the top two suppliers alone account for 20.4% of all Fenofibrate exports, indicating a relatively concentrated supply base.
Across all 168 tracked manufacturers, the total Fenofibrate export value stands at $73.4M from 2.8K shipments. The market average shipment value is $26.3K. The single largest buyer relationship in terms of trade value is YUSEN LOGISTICS BENELUX BELGIUM, receiving $5.9M worth of product.
The combined buyer network spans 19 named purchasing companies, including MYLAN HUNGARY KFT, MYLAN LABORATORIES SAS, DSV AIR & SEA NEDERL, ALPHAPHARM PTY LTD, ALLOGA (NEDERLAND) B.V. and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ABBOTT HEALTHCARE PRIVATE LIMITED
ABBOTT HEALTHCARE PRIVATE LIMITED is the first-largest Fenofibrate exporter from India, with a market share of 11.7% and a total export value of $8.6M across 50 shipments. Their average shipment value of $172.3K is above the market average of $26.3K, suggesting premium or bulk contract pricing.
ABBOTT HEALTHCARE PRIVATE LIMITED serves 5 named buyers in our database. MYLAN HUNGARY KFT is the dominant customer, accounting for 66.8% of this supplier's tracked business. Top customers include:
• MYLAN HUNGARY KFT — $5.8M across 33 shipments (66.8% of this supplier's total exports)
• MYLAN LABORATORIES SAS — $1.8M across 10 shipments (20.8% of this supplier's total exports)
• DSV AIR & SEA NEDERL — $555.7K across 3 shipments (6.5% of this supplier's total exports)
• ALPHAPHARM PTY LTD — $280.1K across 2 shipments (3.3% of this supplier's total exports)
• ALLOGA (NEDERLAND) B.V. — $231.7K across 1 shipments (2.7% of this supplier's total exports)
Key Insight: ABBOTT HEALTHCARE PRIVATE LIMITED's per-shipment value of $172.3K is 556% above the market average of $26.3K, consistent with large-order contracts or value-added formulations.
2SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the second-largest Fenofibrate exporter from India, with a market share of 8.6% and a total export value of $6.3M across 113 shipments. Their average shipment value of $56.1K is above the market average of $26.3K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 93.5% of this supplier's tracked business. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM — $5.9M across 106 shipments (93.5% of this supplier's total exports)
• SUN PHARMA CANADA IN — $142.0K across 3 shipments (2.2% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $122.8K across 2 shipments (1.9% of this supplier's total exports)
• M/S. RANBAXY FARMACE — $76.3K across 1 shipments (1.2% of this supplier's total exports)
• M/S. RANBAXY FARMACE — $69.4K across 1 shipments (1.1% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $56.1K is 114% above the market average of $26.3K, consistent with large-order contracts or value-added formulations.
3CIPLA LIMITED
CIPLA LIMITED is the third-largest Fenofibrate exporter from India, with a market share of 7.6% and a total export value of $5.6M across 329 shipments. Their average shipment value of $16.9K is below the market average of $26.3K, reflecting a high-volume, competitive pricing strategy.
CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $2.2M across 130 shipments (39.5% of this supplier's total exports)
• ARROW PHARMACEUTICALS PTY LTD, — $1.9M across 114 shipments (34.7% of this supplier's total exports)
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $1.1M across 66 shipments (20.0% of this supplier's total exports)
• ARROW PHARMACEUTICALS PTY LTD, — $162.0K across 10 shipments (2.9% of this supplier's total exports)
• ARROW PHARMACEUTICALS PTY LTD, — $161.5K across 10 shipments (2.9% of this supplier's total exports)
Key Insight: CIPLA LIMITED operates with high shipment frequency (329 shipments) at a per-shipment value of $16.9K, indicating a broad distribution network with many smaller, regular orders.
4ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED
ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED is the fourth-largest Fenofibrate exporter from India, with a market share of 4.8% and a total export value of $3.5M across 68 shipments. Their average shipment value of $52.0K is above the market average of $26.3K, suggesting premium or bulk contract pricing.
ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• HANLIM PHARM. CO., LTD — $1.2M across 23 shipments (33.6% of this supplier's total exports)
• HANLIM PHARM CO LIMITED — $992.5K across 19 shipments (28.1% of this supplier's total exports)
• HANLIM PHARM. CO., LTD — $528.1K across 10 shipments (14.9% of this supplier's total exports)
• HANLIM PHARM CO — $415.7K across 8 shipments (11.7% of this supplier's total exports)
• M/S. HANLIM PHARM. C — $412.2K across 8 shipments (11.7% of this supplier's total exports)
Key Insight: ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED's per-shipment value of $52.0K is 98% above the market average of $26.3K, consistent with large-order contracts or value-added formulations.
5AJANTA PHARMA LIMITED
AJANTA PHARMA LIMITED is the fifth-largest Fenofibrate exporter from India, with a market share of 4.2% and a total export value of $3.1M across 105 shipments. Their average shipment value of $29.2K is above the market average of $26.3K, suggesting premium or bulk contract pricing.
AJANTA PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AJANTA PHARMA PHILIPPINES INC — $1.5M across 52 shipments (49.5% of this supplier's total exports)
• XXANTXXPHAXXA UXX IN — $647.6K across 22 shipments (21.2% of this supplier's total exports)
• AJANTA PHARMA USA INC. C/O RXCROSSR — $377.7K across 13 shipments (12.3% of this supplier's total exports)
• AJANTA PHARMA USA INC. C/O RXCROSSR — $272.8K across 9 shipments (8.9% of this supplier's total exports)
• AJANTA PHARMA USA INC. C/O RXCROSSR — $248.1K across 9 shipments (8.1% of this supplier's total exports)
Key Insight: AJANTA PHARMA LIMITED's per-shipment value of $29.2K is 11% above the market average of $26.3K, consistent with large-order contracts or value-added formulations.
6HETERO LABS LIMITED
HETERO LABS LIMITED is the fifth-largest Fenofibrate exporter from India, with a market share of 3.1% and a total export value of $2.3M across 338 shipments. Their average shipment value of $6.8K is below the market average of $26.3K, reflecting a high-volume, competitive pricing strategy.
HETERO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER — $992.9K across 147 shipments (43.4% of this supplier's total exports)
• TO THE ORDER OF — $702.7K across 104 shipments (30.7% of this supplier's total exports)
• M/S — $232.3K across 34 shipments (10.1% of this supplier's total exports)
• CAMBER PHARMACEUTICA — $190.6K across 28 shipments (8.3% of this supplier's total exports)
• TO THE ORDER — $171.7K across 25 shipments (7.5% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED operates with high shipment frequency (338 shipments) at a per-shipment value of $6.8K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Fenofibrate Flows
Once Fenofibrate leaves the manufacturing plants of companies like ABBOTT HEALTHCARE PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED, it travels to 5 destination markets with a combined import value of $73.4M. United States absorbs the largest share at 43.4% ($31.8M), followed by Belgium (8.7%) and Australia (8.2%).
In United States — the top destination — named importers include LIFESTAR PHARMA LLC, CIPLA USA INC UPS SUPPLY CHAIN SOLU, AMNEAL PHARMACEUTICALS, LLC (KY). In Belgium, key buyers are YUSEN LOGISTICS BENELUX BELGIUM.
This geographic spread reflects Fenofibrate's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Fenofibrate Go? Top Importing Countries & Their Buyers
Trade flow of Fenofibrate exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Fenofibrate imports from India, with a total trade value of $31.8M across 763 shipments — representing a 43.4% share of all Fenofibrate exports. The average shipment value of $41.7K is above the global average of $26.3K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.
Named Fenofibrate importers in United States: LIFESTAR PHARMA LLC is the largest buyer, accounting for 14.6% ($4.7M) of this market's total imports.
• LIFESTAR PHARMA LLC — $4.7M (14.6% of United States's total)
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $3.2M (10.0% of United States's total)
• AMNEAL PHARMACEUTICALS, LLC (KY) — $2.7M (8.5% of United States's total)
Key Insight: United States's per-shipment average of $41.7K (59% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Fenofibrate imports from India.
2Belgium
Belgium ranks as the second-largest destination for Fenofibrate imports from India, with a total trade value of $6.4M across 74 shipments — representing a 8.7% share of all Fenofibrate exports. The average shipment value of $86.0K is above the global average of $26.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Fenofibrate importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 97.0% ($6.2M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $6.2M (97.0% of Belgium's total)
Key Insight: Belgium's per-shipment average of $86.0K (228% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Fenofibrate imports from India.
3Australia
Australia ranks as the third-largest destination for Fenofibrate imports from India, with a total trade value of $6.0M across 14 shipments — representing a 8.2% share of all Fenofibrate exports. The average shipment value of $429.2K is above the global average of $26.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Fenofibrate importers in Australia: ARROW PHARMACEUTICALS PTY LTD, is the largest buyer, accounting for 36.8% ($2.2M) of this market's total imports.
• ARROW PHARMACEUTICALS PTY LTD, — $2.2M (36.8% of Australia's total)
Key Insight: Australia's per-shipment average of $429.2K (1535% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Fenofibrate imports from India.
4South Korea
South Korea ranks as the fourth-largest destination for Fenofibrate imports from India, with a total trade value of $4.7M across 9 shipments — representing a 6.4% share of all Fenofibrate exports. The average shipment value of $521.8K is above the global average of $26.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Fenofibrate importers in South Korea: HANLIM PHARM. CO., LTD. is the largest buyer, accounting for 25.3% ($1.2M) of this market's total imports.
• HANLIM PHARM. CO., LTD. — $1.2M (25.3% of South Korea's total)
• HANLIM PHARM CO LIMITED — $992.5K (21.1% of South Korea's total)
• HANLIM PHARM. CO., LTD — $962.5K (20.5% of South Korea's total)
Key Insight: South Korea's per-shipment average of $521.8K (1887% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Korea is a key market for Fenofibrate imports from India.
5France
France ranks as the fifth-largest destination for Fenofibrate imports from India, with a total trade value of $4.7M across 44 shipments — representing a 6.4% share of all Fenofibrate exports. The average shipment value of $105.9K is above the global average of $26.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Fenofibrate importers in France: MYLAN HUNGARY KFT is the largest buyer, accounting for 123.5% ($5.8M) of this market's total imports.
• MYLAN HUNGARY KFT — $5.8M (123.5% of France's total)
• MYLAN LABORATORIES SAS — $3.9M (84.4% of France's total)
Key Insight: France's per-shipment average of $105.9K (303% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Fenofibrate imports from India.
People Also Ask — Fenofibrate Supplier & Trade Network
Who are the top suppliers of Fenofibrate from India?+
Which companies buy Fenofibrate from Indian manufacturers?+
Where does Fenofibrate exported from India go?+
What is the market share of the top Fenofibrate supplier from India?+
What is the average shipment value for Fenofibrate exports from India?+
Is Fenofibrate manufactured in India and exported globally?+
Which country imports the most Fenofibrate from India?+
Who are the buyers of Fenofibrate in Belgium?+
How concentrated is the Fenofibrate supplier market in India?+
How do I find verified buyers for Fenofibrate in specific countries?+
Fenofibrate Trade Network — Key Takeaways
- 1ABBOTT HEALTHCARE PRIVATE LIMITED is India's dominant Fenofibrate exporter with a 11.7% market share and $8.6M in total exports — making it the single most important sourcing entity in this market.
- 2The top 168 suppliers collectively account for 40.1% of all tracked Fenofibrate exports, with a combined trade value of $73.4M.
- 3United States is the largest destination market, absorbing 43.4% of India's Fenofibrate exports ($31.8M). Belgium (8.7%) and Australia (8.2%) follow.
- 4With 2.8K total shipments averaging $26.3K each, the Fenofibrate export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MYLAN HUNGARY KFT, MYLAN LABORATORIES SAS, YUSEN LOGISTICS BENELUX BELGIUM, SUN PHARMA CANADA IN — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 81 countries
Network value: $73.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fenofibrate — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Fenofibrate.
- 2.Flow Mapping: 168 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,794 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 81 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,794 Verified Shipments
168 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists